CorMedix Inc
NASDAQ:CRMD

Watchlist Manager
CorMedix Inc Logo
CorMedix Inc
NASDAQ:CRMD
Watchlist
Price: 12.36 USD 0.82% Market Closed
Market Cap: 838.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-89%
Revenue
Forecast
+44%
Operating Income
Forecast
+67%
Net Income
Forecast
N/A

Wall Street
Price Targets

CRMD Price Targets Summary
CorMedix Inc

Wall Street analysts forecast CRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRMD is 15.81 USD with a low forecast of 12.12 USD and a high forecast of 19.95 USD.

CRMD Lowest Forecast
Wall Street Target
12.12 USD
2% Downside
CRMD Average Forecast
Wall Street Target
15.81 USD
28% Upside
CRMD Highest Forecast
Wall Street Target
19.95 USD
61% Upside
Lowest
Price Target
12.12 USD
2% Downside
Average
Price Target
15.81 USD
28% Upside
Highest
Price Target
19.95 USD
61% Upside
CorMedix Inc Competitors:
Price Targets
FULC
Fulcrum Therapeutics Inc
16% Downside
E
ENZY
Enzymatica AB (publ)
11% Downside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
33% Downside
COPN
Cosmo Pharmaceuticals NV
78% Upside
FULC
Fulcrum Therapeutics Inc
16% Downside
E
ENZY
Enzymatica AB (publ)
11% Downside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
33% Downside
COPN
Cosmo Pharmaceuticals NV
78% Upside
INDOCO
Indoco Remedies Ltd
32% Upside
A
ABBOTINDIA
Abbott India Ltd
10% Upside
HITI
High Tide Inc
121% Upside

Revenue
Forecast

Revenue Estimate
CorMedix Inc

For the last 8 years the compound annual growth rate for CorMedix Inc's revenue is 94%. The projected CAGR for the next 3 years is 86%.

94%
Past Growth
86%
Estimated Growth
Estimates Accuracy
31%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CorMedix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CorMedix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
What are analyst estimates?

See Also

Summary
CRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRMD stock valuation using valuation multiples.
Wall Street Estimates
CRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRMD's stock price target?
Price Target
15.81 USD

According to Wall Street analysts, the average 1-year price target for CRMD is 15.81 USD with a low forecast of 12.12 USD and a high forecast of 19.95 USD.

What is CorMedix Inc's Revenue forecast?
Projected CAGR
86%

For the last 8 years the compound annual growth rate for CorMedix Inc's revenue is 94%. The projected CAGR for the next 3 years is 86%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.